MacroGenics Inc (MGNX:NASDAQ)
$1.955 0.04 (1.82%)
Analysed MacroGenics Inc (MGNX:NASDAQ) News Sources
MacroGenics, Inc.: MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
FinanzNachrichten.de
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Yahoo Finance
MacroGenics stock falls after FDA places partial clinical hold
Investing.com India
Why is MacroGenics stock sinking Tuesday?
Benzinga on MSN
Patient Death Forces Partial Freeze on MacroGenics’ Gynecologic Cancer Study
BioSpace
MacroGenics drops after FDA partial clinical hold on lead program
Seeking Alpha on MSN
FDA freezes enrollment in MacroGenics cancer trial after patient death
Fierce Biotech
MacroGenics Study on Pause After Safety Issues
MarketWatch
After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral
BioSpace
Vivtex’s oral drug delivery approach draws Novo in $2.1B deal
BioWorld
What is the current price of MacroGenics Inc (MGNX:NASDAQ)?
The current price of MacroGenics Inc (MGNX:NASDAQ) is $1.955.
MacroGenics Inc (MGNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MacroGenics Inc (MGNX:NASDAQ) since the previous trading day is $0.04.
MacroGenics Inc (MGNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MacroGenics Inc (MGNX:NASDAQ) since the previous trading day is 1.82%.
What is This Week's average sentiment score for MacroGenics Inc (MGNX:NASDAQ)?
This Week's average sentiment score for MacroGenics Inc (MGNX:NASDAQ) is 71 out of 100.
What is This Week's average sentiment for MacroGenics Inc (MGNX:NASDAQ)?
This Week's sentiment for MacroGenics Inc (MGNX:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.